Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126650451 | 12665045 | 1 | I | 20160428 | 20160811 | 20160818 | 20160818 | EXP | GB-ABBVIE-16P-167-1703325-00 | ABBVIE | 37.00 | YR | F | Y | 0.00000 | 20160818 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126650451 | 12665045 | 1 | PS | NORVIR | RITONAVIR | 1 | Oral | U | UNKNOWN | 20945 | SOFT CAPSULE | ||||||||
| 126650451 | 12665045 | 2 | SS | DOLUTEGRAVIR | DOLUTEGRAVIR | 1 | Oral | Y | 0 | 50 | MG | QD | |||||||
| 126650451 | 12665045 | 3 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | U | 0 | ||||||||||
| 126650451 | 12665045 | 4 | SS | TRIUMEQ | ABACAVIR SULFATEDOLUTEGRAVIR SODIUMLAMIVUDINE | 1 | Oral | U | 0 | ||||||||||
| 126650451 | 12665045 | 5 | SS | DARUNAVIR | DARUNAVIR | 1 | Oral | U | 0 | ||||||||||
| 126650451 | 12665045 | 6 | C | CYCLIZINE | CYCLIZINE | 1 | 0 | ||||||||||||
| 126650451 | 12665045 | 7 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 | ||||||||||||
| 126650451 | 12665045 | 8 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126650451 | 12665045 | 1 | Product used for unknown indication |
| 126650451 | 12665045 | 2 | HIV infection |
| 126650451 | 12665045 | 3 | Antiretroviral therapy |
| 126650451 | 12665045 | 4 | Antiretroviral therapy |
| 126650451 | 12665045 | 5 | Antiretroviral therapy |
| 126650451 | 12665045 | 6 | Product used for unknown indication |
| 126650451 | 12665045 | 7 | Product used for unknown indication |
| 126650451 | 12665045 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126650451 | 12665045 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126650451 | 12665045 | Adverse drug reaction | |
| 126650451 | 12665045 | Anxiety | |
| 126650451 | 12665045 | Mental disorder | |
| 126650451 | 12665045 | Nausea | |
| 126650451 | 12665045 | Stress | |
| 126650451 | 12665045 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126650451 | 12665045 | 2 | 20160511 | 0 | ||
| 126650451 | 12665045 | 4 | 20160419 | 0 |